Basic Information
BlueBird Bio Focuses on the Development of Gene Therapy Treatments, Seeking Breakthrough Therapies for Severe Genetic Disorders. The company's platform treats genetic diseases by inserting healthy genes into bone marrow stem cells extracted from patients and transplanting these corrected stem cells back into the patient’s body, aiming to provide treatment options for those facing potentially fatal conditions with limited therapeutic choices. The company's proprietary technologies in stem cell processing, GMP manufacturing, and gene therapy vectors are also applicable to treating other hereditary diseases.
bluebird bio Inc.
Cambridge,Massachusetts,United States of America
51~100 people
January 01, 1992
info@bluebirdbio.com

